Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Rani Therapeutics Holdings, Inc. (RANI) had Normalized Income after Taxes of $-11.22M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.69M |
|
-- |
|
-- |
|
$10.51M |
|
$-10.51M |
|
$-0.72M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
$-11.22M |
|
|
Normalized Income after Taxes |
$-11.22M |
$-10.51M |
|
$-10.21M |
|
36.54M |
|
36.54M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$11.07M |
|
$1.14M |
|
$5.83M |
|
$16.90M |
|
$20.62M |
|
$2.23M |
|
$5.43M |
|
$26.05M |
|
$-9.15M |
|
$-9.15M |
|
$-9.15M |
|
63.21M |
|
| Cash Flow Statement Financials | |
$-13.95M |
|
$23.94M |
|
$-3.54M |
|
$4.26M |
|
$10.72M |
|
$6.45M |
|
$7.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.54 |
|
-- |
|
-- |
|
-0.32 |
|
-1.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
122.63% |
|
122.63% |
|
-66.42% |
|
162.10% |
|
$-0.14 |
|
$-0.38 |
|
$-0.38 |
|